India’s Precision Medicine: A Vision Hindered by Biobank Regulations

Precision medicine, a transformative approach to healthcare, is redefining the landscape of disease diagnosis and treatment. From groundbreaking personalised healthcare solutions to innovations like mRNA vaccines and gene-editing technologies, the field promises a new era in medical science. Yet, as India stands on the cusp of this revolution, a significant hurdle looms: the lack of robust biobank regulations.

Organ-on-chip device Biobanks, essential repositories of biological samples, are critical to the success of precision medicine. These collections of blood, DNA, and tissue samples, coupled with genetic data, form the backbone of research aimed at developing targeted therapies for diseases like cancer and diabetes. However, as highlighted in a recent analysis by The Hindu, India’s inconsistent biobank regulations threaten public trust and impede progress.

The Promise of Precision Medicine

In recent years, precision medicine has witnessed remarkable achievements. Through gene therapy, researchers have restored vision in individuals with genetic mutations, while in the U.K., scientists have reversed diabetes using reengineered stem cells. The rapid development of COVID-19 vaccines using the mRNA platform, which earned a Nobel Prize, further underscores the potential of precision medicine.

India’s Growing Market

The Indian precision medicine market is burgeoning, with projections estimating a value exceeding $5 billion by 2030. Initiatives like the BioE3 policy and the approval of NexCAR19, a domestically developed CAR-T cell therapy, mark significant strides. However, the true potential of these advancements lies in aligning biobank regulations with international standards.

The Biobank Conundrum

Biobank While countries like the U.K., U.S., and Japan have comprehensive biobank regulations ensuring data protection and privacy, India’s framework remains fragmented. The absence of a single authority to regulate biobanks and the lack of penalties for misconduct create risks of ethical violations and undermine public confidence. As the ICMR guidelines illustrate, participants often consent to provide samples without clarity on data usage, raising concerns about privacy and potential discrimination.

A Path Forward

To harness the full potential of precision medicine, India must establish stringent biobank regulations. Aligning with global standards will not only bolster public trust but also position India as a leader in next-generation therapeutics. As part of international groups like the Quad and BRICS, India has the opportunity to expand its pharmaceutical leadership and enhance its soft diplomatic efforts.

Manjeera Gowravaram, a PhD in RNA biochemistry, provides insightful analysis on the intersection of science and policy.

More Articles

Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!

Florida Homeowners Finally Get a Break as Insurance Rates Begin to Drop

After years of soaring premiums and insurer instability, Florida’s property insurance market is finally turning a corner. Major carriers have filed 83 requests for rate decreases heading into 2026, with companies like Florida Peninsula and Patriot Select proposing cuts of 8.4% and 11.3%. Some homeowners may see relief as early as next month, signaling a long‑awaited shift toward market stability.

The Fix-and-Flip Comeback: Why 2026 Is Poised to Be a Breakout Year for Investors

Fix-and-flip investing is gearing up for one of its strongest years in a decade as 2026 approaches. With cheaper capital, more accessible funding, easing interest rates, and long-awaited increases in housing inventory, investors are finding the perfect environment to launch or scale renovation-based real estate businesses. Renovation continues to outpace new construction in cost and speed, and demand for move-in-ready homes remains high, making 2026 a powerful opportunity window for both new and experienced investors.

Falling Rents Today, Rising Pressures Tomorrow: A 2026 Rental Squeeze Is on the Horizon

After a short-lived period of relief in 2025, the U.S. rental market may be headed for a tighter, more expensive 2026. With construction starts dropping nearly 11% and completions plunging 42%, the surge of new apartments that helped lower rents is rapidly drying up. Rising costs, shrinking inventory, and a slowdown in new development point to a potential rental crunch that could leave renters facing heavier competition and higher prices across major markets next year.

The Biggest Opportunity in Real Estate Since 2008

The commercial real estate market is entering a rare reset that experts say mirrors the post‑2008 boom, creating a potential window for disciplined investors. With trillions in commercial debt coming due and property values dropping up to 40%, firms like AARE are positioning themselves to acquire assets below replacement cost—an advantage that could set the stage for significant long‑term growth.

Six for 2026: The Commercial Real Estate Shifts Already Reshaping the U.S.

Commercial real estate is entering a reinvention phase, with AI‑driven productivity, modernized office demand, experience‑focused retail, expanding industrial logistics, creative housing solutions, and sustainability‑centered design all accelerating nationwide. These six forces are shaping how investors, brokers, and future licensees will operate in a rapidly evolving U.S. market.

2026 Becomes the Turning Point: Innovation, Stability, and Upward Mobility Return

After years of economic uncertainty and cautious decision‑making, 2026 is shaping up to be the year professionals finally catch a break. AI is moving from buzzword to essential tool, capital markets are beginning to thaw, and hiring is picking up across real estate, mortgage, insurance, finance, and healthcare. With opportunity returning, many professionals are using this moment to upskill—pursuing new licenses, certifications, and cross‑industry expertise.